lemaitre.com (LMAT): Operating Profitability

LeMaitre Corp (LMAT) - corporate logo

LeMaitre Vascular, Inc. (LMAT) maintains an impeccable reputation in vascular surgery based on the reliability of its life-critical implants. The operating margin trend reflects the market's assessment of cost efficiency, where the value 27.70 expresses the current state of the metric. High profitability is driven by patents and global sales. Stable leadership and a debt-free balance sheet ensure exceptional capital management discipline.

LMAT - LeMaitre Vascular Operating Profit Ratio over the range 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for LeMaitre Vascular, Inc. (LMAT)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
Fundamental company analysis:LMAT, LeMaitre Corp
Core merchandise of LeMaitre Corp

LeMaitre Vascular, Inc. (LMAT) maintains a diversified portfolio of vascular surgery instruments that ensures operating margin stability, reflecting the profit share from core operations relative to total revenue. An analysis of marginal income from primary activities allows for an assessment of cost management efficiency excluding debt service and taxes, confirming the high resilience of the company's business model to market volatility.

Analysis of competing companies

ISRG (intuitive.com) - Operating Margin|Return on Sales by Operating Profit DHR (Danaher Corp.)|Operating Sales Margin BDX (Becton, Dickinson and Company)|Operating Profit Ratio STE|Operating Profitability West Pharma WST|Profitability of Operations Baxter (BAX)|MASI - Operating Profitability|Profitability of Operations Stevanato Group Corp STVN|TFX: Operating Margin|Operating Sales Margin Merit Medical Systems|Operating Profitability Envista Holdings Corp|Operating Sales Margin ICU Medical Corp (ICUI)|Operating Profitability DENTSPLY SIRONA Inc. (XRAY)|ATRC (AtriCure Corp) - Operating Profit Rate|Operating Margin STAA (STAAR Surgical Co)|ChromaDex Corporation (NAGE) - Operating Return on Sales|ZimVie Inc - Operating Margin|Operating Return on Sales AngioDynamics|CERS (Cerus Corp) - Operating Sales Margin|Alpha Teknova, Inc. - Operating Profit Rate|MGRM (Monogram Orthopedics Inc.) - Operating Margin|STSS: Operating Profit Rate|Operating Sales Margin INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Return on Sales by Operating Profit|Operating Margin KRMD (korumedical.com)|Profitability of Operations Nyxoah, S.A. (NYXH)|MBOT - Operating Profitability|PDEX (Pro-Dex, Inc.) - Return on Sales by Operating Profit|ZTEK (Zentek Ltd) - Operating Sales Margin|ELUT - Profitability of Operations|MLSS (Milestone Scientific Corporation) - Operating Margin|Return on Sales by Operating Profit NXGL (NEXGEL, Inc.)|Operating Margin RVP|Operating Sales Margin Harvard Bioscience HBIO|Operating Margin FEMY (Femasys Corporation)|MHUA - Operating Sales Margin|POAI - Operating Profitability|Callan JMB (CJMB) - Operating Sales Margin|ATRI: Operating Margin|NURO - Profitability of Operations